v3.26.3
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Operating expenses:        
Research and development $ 44,080 $ 50,334 $ 136,917 $ 124,416
Selling, general and administrative 20,081 17,362 61,843 44,636
Total operating expenses 64,161 67,696 198,760 169,052
Loss from operations (64,161) (67,696) (198,760) (169,052)
Other income (expense), net:        
Interest income 6,454 6,412 19,879 20,349
Interest expense (1,714) (917) (3,466) (2,724)
Other (expense) income (5) (18) 5 47
Total other income (expense), net 4,735 5,477 16,418 17,672
Loss before income taxes (59,426) (62,219) (182,342) (151,380)
Income tax expense (109) (102) (229) (273)
Net loss $ (59,535) $ (62,321) $ (182,571) $ (151,653)
Net loss per share, basic $ (1.53) $ (1.77) $ (4.72) $ (4.39)
Net loss per share, diluted $ (1.53) $ (1.77) $ (4.72) $ (4.39)
Weighted-average common shares outstanding-basic 38,904,676 35,178,691 38,695,405 34,516,134
Weighted-average common shares outstanding-diluted 38,904,676 35,178,691 38,695,405 34,516,134
Comprehensive loss:        
Net loss $ (59,535) $ (62,321) $ (182,571) $ (151,653)
Other comprehensive (loss) income:        
Foreign currency translation adjustments 3 0 (9) (1)
Unrealized (loss) gain on marketable securities (1,165) 445 (3,726) 430
Total other comprehensive (loss) income (1,162) 445 (3,735) 429
Comprehensive loss $ (60,697) $ (61,876) $ (186,306) $ (151,224)